Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | GSTM2 | P28161 | 14/20 | 0.44 |
| ▸ | GSTP1 | P09211 | 13/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23612900 | 0.88 | MEN1 (0.52) | MEN1KMT2AGSTM2GSTP1SLC5A2 | |
| SCHEMBL14140891 | 0.88 | MEN1 (0.54) | MEN1KMT2AGSTM2GSTP1SLC5A2 | |
| SCHEMBL6951880 | 0.86 | MEN1 (0.52) | MEN1KMT2AGSTM2GSTP1SLC5A2 | |
| SCHEMBL4295407 | 0.84 | MEN1 (0.38) | MEN1KMT2AGSTM2GSTP1CNR2 | |
| SCHEMBL26025 | 0.83 | MEN1 (0.49) | MEN1KMT2AGSTM2GSTP1CNR2 | |
| SCHEMBL3063567 | 0.81 | MEN1 (0.52) | MEN1KMT2AGSTM2GSTP1KCNH2 | |
| SCHEMBL6123423 | 0.81 | MEN1 (0.51) | MEN1KMT2AGSTM2GSTP1CNR2 | |
| SCHEMBL26054240 | 0.80 | MEN1 (0.56) | MEN1KMT2AGSTM2GSTP1 | |
| SCHEMBL18007677 | 0.79 | KMT2A (0.61) | MEN1KMT2AGSTM2GSTP1CNR2 | |
| SCHEMBL17914175 | 0.79 | MEN1 (0.63) | MEN1KMT2AGSTM2GSTP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346641-A1 | COMPOSITIONS AND METHODS FOR THIN FILAMENT MODULATION | UNIV ARIZONA (US) | 2025-11-13 | — | — | US | claimed |
| US-20240168032-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-23 | — | — | US | claimed |
| EP-3377898-B1 | THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| EP-3377904-B1 | UREA BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| EP-3377897-B1 | LACTATE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| EP-4247968-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | Becton, Dickinson and Company (US) | 2023-09-27 | — | — | EP | claimed |
| US-20220244266-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2022-08-04 | — | — | US | claimed |
| WO-2022109339-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY (US) | 2022-05-27 | — | — | WO | claimed |
| US-20220064226-A1 | Panel comprising Borrelia MHC multimers | IMMUDEX APS (DK) | 2022-03-03 | — | — | US | claimed |
| EP-3898666-A2 | PANEL COMPRISING BORRELIA MHC MULTIMERS | Immudex ApS (DK) | 2021-10-27 | — | — | EP | claimed |
| WO-2010037395-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | claimed |
| EP-2155782-A2 | MHC PEPTIDE COMPLEXES AND USES THEREOF IN INFECTIOUS DISEASES | Dako Denmark A/S (DK) | 2010-02-24 | — | — | EP | claimed |
| WO-2009106073-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | DAKO DENMARK A/S (DK) | 2009-09-03 | — | — | WO | claimed |
| WO-2009039854-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | DAKO DENMARK A/S (DK) | 2009-04-02 | — | — | WO | claimed |
| US-20090054532-A1 | Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation | SIRION THERAPEUTICS, INC. (US) | 2009-02-26 | — | — | US | claimed |
| WO-2008116468-A2 | MHC PEPTIDE COMPLEXES AND USES THEREOF IN INFECTIOUS DISEASES | DAKO DENMARK A/S (DK) | 2008-10-02 | — | — | WO | claimed |
| US-20060094063-A1 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation | SYTERA, INC. (US) | 2006-05-04 | — | — | US | claimed |
| EP-1335984-A1 | DETERMINATION OF HYDROPHOBIC COENZYME A ESTERS AND OTHER LIPIDS USING A BIOSENSOR COMPRISING A MODIFIED COENZYME A- AND ACYL-COA BINDING PROTEIN (ACBP) | Biosensor APS (DK) | 2003-08-20 | — | — | EP | claimed |
| US-20020142347-A1 | Biosensor | BIOSENSOR APS (DK) | 2002-10-03 | — | — | US | claimed |
| WO-2002061096-A1 | DETERMINATION OF HYDROPHOBIC COENZYME A ESTERS AND OTHER LIPIDS USING A BIOSENS OR COMPRISING A MODIFIED COENZYME A- AND ACYL- BINDING PROTEIN (ACBP) | BIOSENSOR APS (DK) | 2002-08-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054532-A1 | Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation | RBP1, TTR, RBP4 | MEN1 4500/4885KMT2A 4838/4885GSTM2 3042/4885 |
| US-20240168032-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | GCK, GCKR, SLC2A4 | MEN1 2391/4885KMT2A 4044/4885GSTM2 1036/4885 |
| US-20220244266-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | GCK, GCKR, SLC2A4 | MEN1 2391/4885KMT2A 4044/4885GSTM2 1036/4885 |
| US-20060094063-A1 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation | RBP1, TTR, RBP4 | MEN1 4500/4885KMT2A 4838/4885GSTM2 3042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.